Results 201 to 210 of about 45,216 (237)

The Role of Bcl-2 Family Proteins and Sorafenib Resistance in Hepatocellular Carcinoma. [PDF]

Int J Cell Biol
de Melo Silva AJ, de Melo Gama JE, de Oliveira SA.   +2 more
europepmc   +1 more source

Transcription factor MEF2D regulates aberrant expression of ACSL3 and enhances sorafenib resistance by inhibiting ferroptosis in HCC. [PDF]

Front Pharmacol
Li X, Chen S, Shi Y, Wang Y, Wang X, Lin Q, Wu C, Fang W, Sun P, Ma L.   +9 more
europepmc   +1 more source

NAT10 inhibition promotes ac4C-dependent ferroptosis to counteract sorafenib resistance in nasopharyngeal carcinoma. [PDF]

Cancer Sci
Xue Z, Xie H, Shan Y, Zhang L, Cheng L, Chen W, Zhu R, Zhang K, Ni H, Zhang Z, You Y, You B.   +11 more
europepmc   +1 more source

CircTTC13 promotes sorafenib resistance in hepatocellular carcinoma through the inhibition of ferroptosis by targeting the miR-513a-5p/SLC7A11 axis. [PDF]

Mol Cancer
Zhang Y, Yao R, Li M, Fang C, Feng K, Chen X, Wang J, Luo R, Shi H, Chen X, Zhao X, Huang H, Liu S, Yin B, Zhong C.   +14 more
europepmc   +1 more source

Loss of lncRNA LINC01056 leads to sorafenib resistance in HCC. [PDF]

Mol Cancer
Chan YT, Wu J, Lu Y, Li Q, Feng Z, Xu L, Yuan H, Xing T, Zhang C, Tan HY, Feng Y, Wang N.   +11 more
europepmc   +1 more source

Exploring the Molecular Mechanism of 1,25(OH)₂D₃ Reversal of Sorafenib Resistance in Hepatocellular Carcinoma Based on Network Pharmacology and Experimental Validation. [PDF]

Curr Issues Mol Biol
Long Z, Wu X, Luo T, Chen X, Huang J, Zhang S.   +5 more
europepmc   +1 more source

MARK1 suppress malignant progression of hepatocellular carcinoma and improves sorafenib resistance through negatively regulating POTEE. [PDF]

Open Med (Wars)
Lu X, Chen Z, Mi W, Zheng J, Liu Y.
europepmc   +1 more source

Circ_0001944 Targets the miR-1292-5p/FBLN2 Axis to Facilitate Sorafenib Resistance in Hepatocellular Carcinoma by Impeding Ferroptosis. [PDF]

Immunotargets Ther
Jing F, Shi Y, Jiang D, Li X, Sun J, Guo Q.   +5 more
europepmc   +1 more source

Tmem39b promotes tumor progression and sorafenib resistance by inhibiting ferroptosis in hepatocellular carcinoma. [PDF]

Oncol Res
Zhuang M, Zhang X, Li LU, Wen L, Qin J.
europepmc   +1 more source

TFCP2L1 drives stemness and enhances their resistance to Sorafenib treatment by modulating the NANOG/STAT3 pathway in hepatocellular carcinoma

Dongbo Qiu, Tiantian Wang, Yi Xiong, Kun Li, Xiusheng Qiu, Yuan Feng, Qinghai Lian, Yunfei Qin, Kunpeng Liu, Qi Zhang, Changchang Jia   +10 more
openalex   +1 more source